Search research articles
Contact Us
Filters
Showing results (201-210 of 234) with videos related to
Page
of 24
Sort By:
Therapeutic Advances in Allergy and Rhinology
|
September 14, 2023
CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of <i>MAGT1</i> Deficiency
Marija J Rowane, Benjamin C Stewart-Bates, Rayna J Doll, et al.
Experimental Cell Research
|
December 20, 2000
The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell lines
H R Ashar, L James, K Gray, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity
F G Njoroge, B Vibulbhan, P Pinto, et al.
Organic Letters
|
May 29, 2000
Synthesis of C-11 methyl-substituted benzocycloheptapyridine inhibitors of farnesyl protein transferase
F G Njoroge, B Vibulbhan, J K Wong, et al.
British Journal of Clinical Pharmacology
|
January 14, 2022
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study
Titia Q Ruijs, Jules A A C Heuberger, Annika A de Goede, et al.
Journal of Pharmaceutical Sciences
|
June 2, 2007
Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz)
J Zh Gao, M A Hussain, R Motheram, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
October 17, 1998
In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy
P H Marathe, E P Sandefer, G E Kollia, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2005
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc
Chia-Yu Huang, Tara M Stauffer, Corey L Strickland, et al.
Clinical Pharmacology and Therapeutics
|
May 14, 2026
Transcranial Magnetic Stimulation as a Translational Biomarker in Early-Phase Anti-Seizure Medication Development: A Randomized, Double-Blind, Placebo-Controlled Study in Generalized Epilepsy
Catherine M E de Cuba, Titia Q Ruijs, Annika A de Goede, et al.
Clinical Pharmacology and Therapeutics
|
December 6, 2024
TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects
Catherine M K E de Cuba, Annika A de Goede, Erica S Klaassen, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 234) with videos related to
Sort By:
Page
of 24
Therapeutic Advances in Allergy and Rhinology
|
September 14, 2023
CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of <i>MAGT1</i> Deficiency
Marija J Rowane, Benjamin C Stewart-Bates, Rayna J Doll, et al.
Experimental Cell Research
|
December 20, 2000
The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell lines
H R Ashar, L James, K Gray, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity
F G Njoroge, B Vibulbhan, P Pinto, et al.
Organic Letters
|
May 29, 2000
Synthesis of C-11 methyl-substituted benzocycloheptapyridine inhibitors of farnesyl protein transferase
F G Njoroge, B Vibulbhan, J K Wong, et al.
British Journal of Clinical Pharmacology
|
January 14, 2022
Transcranial magnetic stimulation as biomarker of excitability in drug development: A randomized, double-blind, placebo-controlled, cross-over study
Titia Q Ruijs, Jules A A C Heuberger, Annika A de Goede, et al.
Journal of Pharmaceutical Sciences
|
June 2, 2007
Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz)
J Zh Gao, M A Hussain, R Motheram, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
October 17, 1998
In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy
P H Marathe, E P Sandefer, G E Kollia, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2005
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zinc
Chia-Yu Huang, Tara M Stauffer, Corey L Strickland, et al.
Clinical Pharmacology and Therapeutics
|
May 14, 2026
Transcranial Magnetic Stimulation as a Translational Biomarker in Early-Phase Anti-Seizure Medication Development: A Randomized, Double-Blind, Placebo-Controlled Study in Generalized Epilepsy
Catherine M E de Cuba, Titia Q Ruijs, Annika A de Goede, et al.
Clinical Pharmacology and Therapeutics
|
December 6, 2024
TMS and EEG Pharmacodynamic Effects of a Selective Sphingosine-1-Phosphate Subtype 1 Receptor Agonist on Cortical Excitability in Healthy Subjects
Catherine M K E de Cuba, Annika A de Goede, Erica S Klaassen, et al.
Page
of 24